Drug profile

The FDA adverse-event record for Device: Animal Care (Bowls, Crates, Etc)

19 FDA reports name Device: Animal Care (Bowls, Crates, Etc), a lower-volume drug in the CVM extract. Species, reactions, and outcomes follow.

#1833 of 2,679
by report volume (all drugs)
19
adverse-event reports
15.8%
death-coded share
Cat
most-reported species

Corpus placement

According to the FDA Center for Veterinary Medicine openFDA adverse-event extract, Device: Animal Care (Bowls, Crates, Etc) ranks #1827 of 2679 by total reports (19). Death-coded-share rank requires at least 50 reports. National dual: Milbemycin Oxime + Spinosad is #1 of 2679 drugs by total adverse-event reports (149,624) at death-coded-share rank 965 of 1130 drugs with at least 50 reports (2.3%); separately, Atlantic Salmon Transgenic Whole (Opafp-Ghc2 Rdna Construct Inserted Into The A-Locus In The Eo-1A Lineage) is #1 highest death-coded share at 97.8% (report rank #821).

149,624
Milbemycin Oxime + Spinosad reports (#1)
97.8%
Atlantic Salmon Transgenic Whole (Opafp-Ghc2 Rdna Construct Inserted Into The A-Locus In The Eo-1A Lineage) death share (#1)
#1827
This drug, reports of 2679

Report volume reflects how common a breed or drug is and how often owners and vets file — not actual risk. Death-coded share ranks are limited to entries with enough reports to be meaningful. The two maps do not agree at #1.

Release-over-release change

What changed in the latest FDA data snapshot

PlainBreed reconstructed the prior snapshot from dated openFDA partitions through 2025 Q4, then compared it with the 2026-07-27 openFDA export. Device: Animal Care (Bowls, Crates, Etc) has 19 reports now versus 19 in that prior snapshot: 0 the same number of (0.0%).

Report change
+0
Death-coded reports
+0
Death-coded share
−0.0 pts

This compares reported-event counts in two source snapshots. It does not establish a change in real-world risk, product safety, or disease incidence.

Subscribe to Device: Animal Care (Bowls, Crates, Etc) changes

Signature read: 19 reports place Device: Animal Care (Bowls, Crates, Etc) in the lower third of FDA AER volume (#1833 of 2,679).

Important: Adverse event reports do not establish that a drug caused or contributed to the event. Consult your veterinarian before making treatment decisions.
19
Total Reports
3
Deaths Reported
15.8%
Death-coded share of reports

Active Ingredients

Device: Animal Care (Bowls, Crates, Etc)

Administration Routes

UnknownOralRespiratory (Inhalation)OtherUnassignedTopical

Species Affected

Cat 8
Dog 3
Unknown 3
Human 3
Hamster 1
Fish 1

Most Affected Breeds

Unknown 7
Cat (unknown) 3
Dog (unknown) 2
Pekingese 1
Maine Coon 1
Mixed (Cat) 1
Hamster (unknown) 1
Zebrafish 1
American Shorthair 1
Crossbred Feline/cat 1

Most Reported Reactions

Device Defective NOS 4
Foreign body, medical device 3
Death 2
Asphyxia 2
Product Defect, General 2
Dyspnoea 2
Vomiting 2
Digestive tract stenosis and obstruction NOS 1
Gastroenteritis 1
Abnormal radiograph finding 1
Sinusitis 1
Sneezing 1

Outcome Breakdown

Outcome Unknown
8 (57.1%)
Died
2 (14.3%)
Recovered/Normal
2 (14.3%)
Ongoing
1 (7.1%)
Euthanized
1 (7.1%)

Device: Animal Care (Bowls, Crates, Etc): lower report volume in the FDA AER row

Read these counts as reporting volume, not risk: per our methodology, a widely-prescribed drug will rack up more raw FDA reports in a given year than a rarely-used one at an identical true rate, so we recommend comparing within similar-exposure products rather than across the full 2025 catalog.

What to do with this drug

A report does not prove a drug caused the reaction; consult a veterinarian before acting on this data.

Source: FDA Center for Veterinary Medicine openFDA Animal & Veterinary Adverse Events (CVM AER) · 2025

openFDA Animal & Veterinary Adverse Events (FDA CVM) for Device: Animal Care (Bowls, Crates, Etc) (#1833 of 2,679 by report volume); death-coded 15.8%. PlainBreed drug row · report volume stamp 19 · vintage 2025.

Informational only. FDA adverse-event reports are voluntary and do not prove causation; consult a veterinarian before acting on them. Verify with FDA CVM →